Bellerophon Therapeutics Inc (BLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,831 | -17,756 | -24,728 | -13,267 | 2,814 |
| Depreciation Amortization | 65 | 102 | 147 | 348 | 362 |
| Other Working Capital | 1,211 | -5,693 | 2,437 | -161 | 3,251 |
| Other Operating Activity | 785 | 526 | 2,260 | 144 | -21,922 |
| Operating Cash Flow | $-17,770 | $-22,821 | $-19,884 | $-12,936 | $-15,495 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 3,000 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $3,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 57,753 | 6,236 | 166 |
| Other Financing Activity | -40 | 0 | -186 | -69 | 0 |
| Financing Cash Flow | $-40 | $N/A | $57,567 | $6,167 | $166 |
| Beginning Cash Position | 25,139 | 47,960 | 10,277 | 17,046 | 29,375 |
| End Cash Position | 7,329 | 25,139 | 47,960 | 10,277 | 17,046 |
| Net Cash Flow | $-17,810 | $-22,821 | $37,683 | $-6,769 | $-12,329 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,770 | -22,821 | -19,884 | -12,936 | -15,495 |
| Free Cash Flow | -17,770 | -22,821 | -19,884 | -12,936 | -15,495 |